BioTechX 2025 is Europe’s flagship event for decision makers and thought leaders working in omics, diagnostics and R&D from across Europe and beyond. This year’s event will be bigger than ever with 3500+ senior decision makers in attendance.
From multiomic data management to the development of personalised therapies and data generation this event brings together the advancements in AI and Drug development, quantum pharma, precision medicine, big data and much more.
Cambridge Consultants will be at Capgemini booth #513 during the event to meet with clients and discuss new advancements in biotech. Please stop by if you are attending the show.
Joe leads Artificial Intelligence and Digital product strategy and development in high criticality applications. He has led the R&D of high risk (class 2/3) medical devices in robotics, neurosurgery cardiovascular imaging, diabetes, histopathology and biomarkers, as well as strategic transformation via large scale medical data and video systems, consumer health and financial platforms. He is named inventor on >25 patent families.
Ben has focused on science and engineering of medical devices and diagnostics for over 25 years. He has worked across patient monitoring, surgical navigation, in-vitro diagnostics and drug delivery.
Helping our clients develop breakthrough medical devices. Simon helps to bring unparalleled technology, clinical insight and medical device development experience to developing advanced emerging medical technologies and therapies such as Synthetic Biology, Artificial Intelligence, Digital Health, Smart Implants and Cell & Gene Therapies.